Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
Carrillo, F., Sigman, M., Slezak, D. F., Ashton, P., Fitzgerald, L., Stroud, J., ... & Carhart-Harris, R. L. | Journal of affective disorders | 30 March 2018
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. | Handbook of Experimental Pharmacology | 13 March 2018
Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. | Behavioural pharmacology | 13 March 2018
The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity
Hartogsohn, I. | Frontiers in neuroscience | 6 March 2018
Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
Schindler, E. A. D., Wallace, R. M., Sloshower, J. A., & D'Souza, D. C. | Frontiers in pharmacology | 1 March 2018
The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions
Nielson, E. M., May, D. G., Forcehimes, A. A., & Bogenschutz, M. P. | Frontiers in Pharmacology | 21 February 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder
Bogenschutz, M. P., Podrebarac, S. K., Duane, J. H., Amegadzie, S. S., Malone, T. C., Owens, L. T., ... & Mennenga, S. E. | Frontiers in Pharmacology | 20 February 2018
Powerful substances in tiny amounts An interview study of psychedelic microdosing
Johnstad, P. G. | Nordic Studies on Alcohol and Drugs | 15 February 2018
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation
Curran, H. V., Nutt, D., & de Wit, H. | Psychopharmacology | 14 February 2018
Serotonergic psychedelics and personality: A systematic review of contemporary research
Bouso, J. C., dos Santos, R. G., Alcázar-Córcoles, M. Á., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 13 February 2018
Evaluating the abuse potential of psychedelic drugs for medical use in humans
Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018
The hidden therapist: evidence for a central role of music in psychedelic therapy
Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., ... & Carhart-Harris, R. | Psychopharmacology | 2 February 2018
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Branchi, I., & Kaelen, M. | Journal of Psychopharmacology | 1 February 2018
Taking Psychedelics Seriously
Byock, I. | Journal of palliative medicine | 22 January 2018
Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers
Bravermanová, A., Viktorinová, M., Tylš, F., Novák, T., Androvičová, R., Korčák, J., ... & Vlček, P. | Psychopharmacology | 5 January 2018
The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports
Tagliazucchi, E., & Sanz, C. | Frontiers in Neuroscience | 4 January 2018
Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
Lyons, T., & Carhart-Harris, R. L. | Journal of Psychopharmacology | 1 January 2018
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. | Neuropharmacology | 27 December 2017
Psychiatry & the psychedelic drugs. Past, present & future.
Rucker, J. J., Iliff, J., & Nutt, D. J. | Neuropharmacology | 25 December 2017
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. | Frontiers in Pharmacology | 20 December 2017
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., ... & Rickard, J. A. | Psychopharmacology | 8 November 2017
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. | Psychopharmacology | 7 November 2017
Multipotent and Poly-therapeutic Fungal Alkaloids of Claviceps purpurea
Majrashi, M., Ramesh, S., Deruiter, J., Mulabagal, V., Pondugula, S., Clark, R., & Dhanasekaran, M. | Medicinal Plants and Fungi: Recent Advances in Research and Development | 4 November 2017
Dying to live: The power of transcendence in the treatment of existential anxiety
Gandy, S. | Threshold: Journal of Interdisciplinary Consciousness Studies | 2 November 2017